Drawing for CELLTRION CONNECT

USPTO serial 79305125

CELLTRION CONNECT

Reviewed by CopyMark Law Group

Reg. 6726756Status 700Registered
Filing date
Status date
Registration date
May 24, 2022
Examiner
GORAN, BRADLEY TAYLOR
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with CELLTRION CONNECT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kisuk Lee

Kisuk Lee Harness, Dickey & Pierce, PLC7700 Bonhomme Ave, Suite 400St. Louis, MO 63105UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
044Healthcare; health counselling; medical and health care services; medical information services provided via the internet; Information services relating to medical products, namely, providing information concerning the proper use of medical treatment apparatus and instruments for biopharmaceutical use; Providing consultancy and information services in the field of biopharmaceutical products; Providing consultancy and information services in the field of pharmaceutical products; Providing consultancy and information services provided via the internet in the field of pharmaceutical products; providing consultancy in the field of pharmaceuticals; providing consultancy in the field of medical products in the nature of diagnostic medical testing; medical consultancy for selecting appropriate medicines; providing information in the field of medicine; advisory services relating to pharmaceutical products; advisory services relating to health care; patient support services for disease diagnosis and treatment in the field of autoimmune disease; patient support services in the field of medical autoimmune disease treatmentACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 21, 2023ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Dec 2, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 2, 2022FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Sep 8, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Sep 8, 2022FIMPFINAL DISPOSITION PROCESSED—
Aug 24, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 24, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 24, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 10, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
Dec 29, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Dec 6, 2021GPNXNOTIFICATION PROCESSED BY IB—
Nov 30, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 30, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 17, 2021OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Nov 17, 2021OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Nov 10, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 28, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 28, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Oct 28, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 28, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 28, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 16, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 16, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 16, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 16, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 16, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 16, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 16, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 9, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 12, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Apr 5, 2021RFNTREFUSAL PROCESSED BY IB—
Mar 18, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 17, 2021RFRRREFUSAL PROCESSED BY MPU—
Mar 17, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 16, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 16, 2021DOCKASSIGNED TO EXAMINER—
Mar 5, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 1, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 25, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance